[The 505th case: refractory ascites and monoclonal immunoglobulin]

Zhonghua Nei Ke Za Zhi. 2024 May 1;63(5):517-520. doi: 10.3760/cma.j.cn112138-20231208-00373.
[Article in Chinese]

Abstract

A 52-year-old woman was admitted with a primary complaint of abdominal distension and increased abdominal circumference for more than half a year. There was no evidence of infection or solid tumor on abdominocentesis or laparoscopic surgery. Concurrently, smoldering multiple myeloma was diagnosed. Due to refractory ascites and portal hypertension, a transjugular intrahepatic portosystemic shunt was performed, but the efficacy was not satisfactory. As the anemia progressed, she was finally diagnosed with active multiple myeloma after monoclonal plasma cells were detected in the ascites by flow cytometry. Treated with a triplet regimen that included bortezomib, cyclophosphamide, and dexamethasone (BCD), she achieved a very good partial response and ascites regressed.

患者女,52岁,因反复腹胀、腹围增大半年余就诊。病初行腹腔积液穿刺及腹腔镜手术均无感染、实体瘤证据,同期诊断冒烟型多发性骨髓瘤。后因顽固性腹水、门静脉高压,行经颈静脉肝内门腔静脉分流术,效果欠佳。最终腹水流式细胞术发现异常单克隆浆细胞,进行性贫血,诊断多发性骨髓瘤。采用BCD方案(硼替佐米、环磷酰胺、地塞米松)抗浆细胞治疗后腹腔积液消失。.

Publication types

  • Case Reports
  • English Abstract

MeSH terms

  • Antibodies, Monoclonal / therapeutic use
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Ascites* / etiology
  • Bortezomib / therapeutic use
  • Cyclophosphamide / therapeutic use
  • Dexamethasone / administration & dosage
  • Dexamethasone / therapeutic use
  • Female
  • Humans
  • Hypertension, Portal
  • Middle Aged
  • Multiple Myeloma* / complications

Substances

  • Dexamethasone
  • Cyclophosphamide
  • Bortezomib
  • Antibodies, Monoclonal